LOVENOX® (enoxaparin sodium injection) is a unique chemical entity in a class of antithrombotic agents known as low-molecular-weight heparins (LMWH). LOVENOX® was approved in the United States and Canada in 1993, and it has been available in Europe since 1987. LOVENOX® is the only low-molecular-weight heparin in the United States approved by the Food and Drug Administration in 7 approved indications for the prophylaxis and treatment of thromboembolic disease.(more...)


Other sites.

http://www.lovenox.com/consumer/default.aspx

http://www.medicinenet.com/enoxaparin-injection/article.htm

http://products.sanofi-aventis.us/lovenox/lovenox.html